Clinical Trials in Shymkent, Kazakhstan
3 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)385 enrolled159 locationsNCT06226883
Recruiting
Clinical Efficacy of Ustekinumab in Crohn's Disease
Crohn's Disease
Kazakhstan Scientific Society for Study of intestine diseases150 enrolled4 locationsNCT06523647